Neal Flomenberg files SEC Form 4 disclosures for Tevogen Bio Holdings Inc.. They have made 5 open-market trades across 1 company since 2024, most recently 2026-03-13.
CIK 0002011757
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TVGN | 76,940 | $466K |
Shares reported on the most recent Form 4, priced at the 2026-03-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVGN | SELL | 2026-03-10 | 2026-03-17 | $6.83 | $7K | -16.4% | +12.8% | +112.3% |
| TVGN | SELL | 2025-03-12 | 2025-03-14 | $1.09 | $508K | +5.4% | -5.4% | +14.4% |
| TVGN | SELL | 2025-03-07 | 2025-03-11 | $1.09 | $463K | +5.6% | -7.4% | +1.9% |
| TVGN | SELL | 2025-03-04 | 2025-03-06 | $1.17 | $481K | +0.9% | -9.6% | +14.0% |
| TVGN | SELL | 2024-10-17 | 2024-10-18 | $1.62 | $1.7M | +28.8% | -30.4% | -36.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.